(Allergan plc)

	AGN latest price $188.9372 (2.77%) ($184.3314 - $189.9772) on Mon. Aug. 20, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.42% (three month average)
RSI	76
Latest Price	$188.9372(2.77%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.8% a day on average for past five trading days.
Weekly Trend	AGN advances 0.5% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Value stock rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XBI(48%)    XLV(48%)    ARKG(46%)    IVW(45%)
Factors Impacting AGN price	AGN will decline at least -0.71% in a week (0% probabilities).   VIXM(-28%)    TLT(-22%)    UUP(-19%)    VXX(-15%)    DIA(-11%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.71% (StdDev 1.42%)
Hourly BBV	0 ()
Intraday Trend	2.5%

5 Day Moving Average	$183.85(2.77%)
10 Day Moving Average	$183.03(3.23%)
20 Day Moving Average	$181.2(4.27%)
To recent high	0%
To recent low	27%
Market Cap	$62.293b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed